Abstract:Abstract Recent reports revealed that endothelial progenitor cells (EPCs) isolated from bone marrow, cord blood or embryos have been experimentally utilized to deliver therapeutic agents for cancer treatment. Their potential in cancer therapy highlights the need for a consistent and renewable source of endothelial cells for clinical applications. Moreover, one of the most critical issues for ensuring success of endothelial therapy is the development of technologies for non-invasive monitoring of the distribution of transplanted cells and kinetic of tumor progression or regression. We generated human embryonic stem cell-derived endothelial cells (hESC-ECs) from H9 cell line. The hESC-ECs resemble adult endothelial cells HUVEC in endothelial markers and angiogenesis potential. In vitro study revealed the paracrine effects of hESC-ECs on tumor cells using conditioned medium (EC-CM). After treated with EC-CM, human breast cancer cells MDA-MB-231 proliferated slower and exhibited a higher apoptosis rate in low-serum condition, and the migration ability was impaired. Furthermore, we introduced a multitude of non-invasive, quantitative, functional imaging techniques with reporter gene methods to probe breast cancer model processes, and to track the hESC-ECs for targeting therapy in vivo by firefly luciferase (Fluc)/renilla luciferase (Rluc) imaging. We transduced hESC-ECs with triple fusion (TF) reporter gene containing the herpes simplex virus truncated thymidine kinase (HSV-ttk), renilla luciferase (Rluc) and RFP (RL-RFP-HSV-ttk). The NOD/SCID mice breast cancer metastasis model was established by tail vein injection of 1.5×106 MDA-MB-231 cells, which carry a reporter system encoding the gene of Fluc and GFP. Bioluminescence imaging (BLI) revealed that hESC-ECs can be sequenced in tumor sites for more than 72 hours. When given pro-drug ganciclovir (GCV), targeting HSV-ttk gene, the MDA-MB-231 tumor was inhibited by the indication of Fluc imaging. And immunofluorescence staining also confirmed that hESC-EC can exclusively home to tumor lesions instead of normal lung tissue. Taken together, our results revealed that hESC-ECs can specifically target tumor sites and kill nearby tumor cells by bystander effect when GCV is given. These finds suggest that hESC-ECs are attractive targeting vehicles for cancer therapy, and molecular imaging in small animals is an invaluable part of cancer diagnosis, prediction of tumor response to available therapies and monitoring response to therapy as well as developing drugs prior to clinical translation. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 415. doi:1538-7445.AM2012-415

Molecular Imaging for Assessment of Mesenchymal Stem Cells Mediated Breast Cancer Therapy.

Traceable Therapeutic Strategy for Treatment of Breast Cancer with Mesenchymal Stem Cells (MSCs)

Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy.

Molecular imaging: a useful tool for translational research of stem cells

Molecular Imaging in Tracking Tumor Stem-Like Cells

Multimodal Imaging-Guided Spatiotemporal Tracking of Photosensitive Stem Cells for Breast Cancer Treatment

In Vivo Tracking of the Tropism of Mesenchymal Stem Cells to Malignant Gliomas Using Reporter Gene-Based MR Imaging

A Light-Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo-Photothermal Therapy of Triple Negative Breast Cancer.

Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-κB activity

Multimodality Imaging in the Assessment of Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy.

Imaging of Human Mesenchymal Stromal Cells: Homing to Human Brain Tumors

Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence

Influence of mesenchymal stem cells on metastasis development in mice in vivo

Unveiling the improved targeting migration of mesenchymal stem cells with CXC chemokine receptor 3-modification using intravital NIR-II photoacoustic imaging

Dual Targeting and Enhanced Cytotoxicity to HER2-overexpressing Tumors by Immunoapoptotin-Armored Mesenchymal Stem Cells.

E0009 Multimodality Molecular Imaging of Adipose-Derived Mesenchymal Stem Cells with VEGF in Hindlimb Ischaemia Mice

Fluorescent Magnetic Nanoparticle-Labeled Mesenchymal Stem Cells for Targeted Imaging and Hyperthermia Therapy of in Vivo Gastric Cancer

The in Vitro and in Vivo Effects of Human Umbilical Cord Mesenchymal Stem Cells on the Growth of Breast Cancer Cells

Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo.

Human Embryonic Stem Cell-Derived Endothelial Cells As Cellular Delivery Vehicles for Targeting Therapy of Metastatic Breast Cancer

Ultrasensitive in Vivo Fluorescence Imaging of Mesenchymal Stem Cells and Small Molecule-Induced Pluripotent Stem Cells in BALB/c mice.